Surgical Innovations Group plc (SUN) - Net Assets

Latest as of December 2025: GBX7.65 Million GBX ≈ $930.30 USD

Based on the latest financial reports, Surgical Innovations Group plc (SUN) has net assets worth GBX7.65 Million GBX (≈ $930.30 USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (GBX11.64 Million ≈ $1.42K USD) and total liabilities (GBX4.00 Million ≈ $486.08 USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore balance sheet size of Surgical Innovations Group plc for the complete picture of this company's asset base.

Key Net Assets Metrics

Metric Value
Current Net Assets GBX7.65 Million
% of Total Assets 65.68%
Annual Growth Rate 5.16%
5-Year Change -28.3%
10-Year Change 30.97%
Growth Volatility 114.37

Surgical Innovations Group plc - Net Assets Trend (1989–2025)

This chart illustrates how Surgical Innovations Group plc's net assets have evolved over time, based on quarterly financial data. Check tangible equity quality of Surgical Innovations Group plc to evaluate the tangible quality of the company's equity base.

Annual Net Assets for Surgical Innovations Group plc (1989–2025)

The table below shows the annual net assets of Surgical Innovations Group plc from 1989 to 2025. For live valuation and market cap data, see SUN market cap.

Year Net Assets Change
2025-12-31 GBX7.65 Million
≈ $930.30		 -10.48%
2024-12-31 GBX8.54 Million
≈ $1.04K		 -18.53%
2023-12-31 GBX10.48 Million
≈ $1.28K		 -4.37%
2022-12-31 GBX10.96 Million
≈ $1.33K		 +2.80%
2021-12-31 GBX10.66 Million
≈ $1.30K		 -3.84%
2020-12-31 GBX11.09 Million
≈ $1.35K		 -9.04%
2019-12-31 GBX12.19 Million
≈ $1.48K		 -15.47%
2018-12-31 GBX14.42 Million
≈ $1.75K		 +5.15%
2017-12-31 GBX13.72 Million
≈ $1.67K		 +134.94%
2016-12-31 GBX5.84 Million
≈ $710.32		 +48.55%
2015-12-31 GBX3.93 Million
≈ $478.17		 -35.77%
2014-12-31 GBX6.12 Million
≈ $744.51		 -57.84%
2013-12-31 GBX14.52 Million
≈ $1.77K		 +7.02%
2012-12-31 GBX13.56 Million
≈ $1.65K		 +7.51%
2011-12-31 GBX12.62 Million
≈ $1.54K		 +19.15%
2010-12-31 GBX10.59 Million
≈ $1.29K		 +22.55%
2009-12-31 GBX8.64 Million
≈ $1.05K		 +7.46%
2008-12-31 GBX8.04 Million
≈ $978.24		 +8.50%
2007-12-31 GBX7.41 Million
≈ $901.58		 +164.74%
2006-12-31 GBX2.80 Million
≈ $340.56		 +33.67%
2005-12-31 GBX2.09 Million
≈ $254.78		 +26.91%
2004-12-31 GBX1.65 Million
≈ $200.76		 +18.28%
2003-12-31 GBX1.40 Million
≈ $169.73		 +11.78%
2002-12-31 GBX1.25 Million
≈ $151.85		 +9.38%
2001-12-31 GBX1.14 Million
≈ $138.83		 +8.05%
2000-12-31 GBX1.06 Million
≈ $128.48		 +238.58%
1999-12-31 GBX-762.00K
≈ $-92.71		 -1020.59%
1998-12-31 GBX-68.00K
≈ $-8.27		 -107.00%
1997-12-31 GBX972.00K
≈ $118.26		 +383.58%
1996-08-31 GBX201.00K
≈ $24.46		 -83.26%
1995-08-31 GBX1.20 Million
≈ $146.13		 -56.39%
1994-08-31 GBX2.75 Million
≈ $335.08		 -48.22%
1993-08-31 GBX5.32 Million
≈ $647.17		 +288.53%
1992-08-31 GBX1.37 Million
≈ $166.57		 -18.61%
1991-08-31 GBX1.68 Million
≈ $204.65		 +402.09%
1990-08-31 GBX335.00K
≈ $40.76		 -72.74%
1989-08-31 GBX1.23 Million
≈ $149.53		 --

Equity Component Analysis

This analysis shows how different components contribute to Surgical Innovations Group plc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 837300000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Common Stock GBX9.33 Million 122.00%
Other Comprehensive Income GBX329.00K 4.30%
Other Components GBX6.59 Million 86.15%
Total Equity GBX7.65 Million 100.00%

Surgical Innovations Group plc Competitors by Market Cap

The table below lists competitors of Surgical Innovations Group plc ranked by their market capitalization.

Company Market Cap
MOLECULE HOLDINGS
F:ERV2
 $57.16K
Bisichi Mining PLC
LSE:BISI
 $57.16K
Harmony Energy Income Trust PLC
LSE:HEIT
 $57.20K
Philipp Holzmann AG
DU:HOZ
 $57.22K
Trakm8 Holdings PLC
LSE:TRAK
 $56.24K
Nanoco Group plc
LSE:NANO
 $55.49K
MyHealthChecked Plc
LSE:MHC
 $55.40K
Contango Holdings PLC
LSE:CGO
 $55.33K

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Surgical Innovations Group plc's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 8,541,000 to 7,646,000, a change of -895,000 (-10.5%).
  • Net loss of 895,000 reduced equity.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income GBX-895.00K -11.71%
Total Change GBX- -10.48%

Book Value vs Market Value Analysis

This analysis compares Surgical Innovations Group plc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 61.00x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has increased from 14.51x to 61.00x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
1989-08-31 GBX0.03 GBX0.50 x
1990-08-31 GBX0.01 GBX0.50 x
1991-08-31 GBX0.04 GBX0.50 x
1992-08-31 GBX0.03 GBX0.50 x
1993-08-31 GBX0.13 GBX0.50 x
1994-08-31 GBX0.07 GBX0.50 x
1995-08-31 GBX0.03 GBX0.50 x
1996-08-31 GBX0.00 GBX0.50 x
1998-12-31 GBX0.00 GBX0.50 x
1999-12-31 GBX0.00 GBX0.50 x
2000-12-31 GBX0.00 GBX0.50 x
2001-12-31 GBX0.00 GBX0.50 x
2002-12-31 GBX0.00 GBX0.50 x
2003-12-31 GBX0.01 GBX0.50 x
2004-12-31 GBX0.01 GBX0.50 x
2005-12-31 GBX0.01 GBX0.50 x
2006-12-31 GBX0.01 GBX0.50 x
2007-12-31 GBX0.02 GBX0.50 x
2008-12-31 GBX0.02 GBX0.50 x
2009-12-31 GBX0.02 GBX0.50 x
2010-12-31 GBX0.03 GBX0.50 x
2011-12-31 GBX0.03 GBX0.50 x
2012-12-31 GBX0.03 GBX0.50 x
2013-12-31 GBX0.04 GBX0.50 x
2014-12-31 GBX0.01 GBX0.50 x
2015-12-31 GBX0.01 GBX0.50 x
2016-12-31 GBX0.01 GBX0.50 x
2017-12-31 GBX0.02 GBX0.50 x
2018-12-31 GBX0.02 GBX0.50 x
2019-12-31 GBX0.02 GBX0.50 x
2020-12-31 GBX0.01 GBX0.50 x
2021-12-31 GBX0.01 GBX0.50 x
2022-12-31 GBX0.01 GBX0.50 x
2023-12-31 GBX0.01 GBX0.50 x
2024-12-31 GBX0.01 GBX0.50 x
2025-12-31 GBX0.01 GBX0.50 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Surgical Innovations Group plc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -11.71%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -7.71%
  • • Asset Turnover: 1.00x
  • • Equity Multiplier: 1.52x
  • Recent ROE (-11.71%) is above the historical average (-44.37%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
1989 -18.31% -340.91% 0.03x 1.84x GBX-347.90K
1990 -266.57% -276.47% 0.24x 4.09x GBX-926.50K
1991 -104.16% -593.90% 0.10x 1.81x GBX-1.92 Million
1992 -123.23% -249.56% 0.24x 2.08x GBX-1.82 Million
1993 -40.01% -189.32% 0.17x 1.25x GBX-2.66 Million
1994 -85.48% -1110.38% 0.05x 1.44x GBX-2.63 Million
1995 -209.41% -391.74% 0.26x 2.07x GBX-2.64 Million
1996 -613.93% -266.52% 0.65x 3.55x GBX-1.25 Million
1998 0.00% -64.23% 0.71x 0.00x GBX-1.07 Million
1999 0.00% -55.30% 0.70x 0.00x GBX-617.80K
2000 -5.40% -3.18% 1.07x 1.59x GBX-162.60K
2001 7.36% 4.55% 1.01x 1.60x GBX-30.10K
2002 6.25% 3.51% 0.96x 1.85x GBX-46.80K
2003 9.96% 5.05% 0.96x 2.05x GBX-500.00
2004 12.85% 6.99% 1.04x 1.76x GBX47.00K
2005 19.20% 10.00% 1.28x 1.50x GBX192.60K
2006 24.87% 15.61% 1.14x 1.40x GBX416.10K
2007 10.32% 16.04% 0.51x 1.26x GBX24.00K
2008 7.84% 14.61% 0.39x 1.38x GBX-174.00K
2009 6.08% 11.56% 0.39x 1.34x GBX-339.00K
2010 16.89% 25.38% 0.52x 1.28x GBX729.20K
2011 13.78% 22.86% 0.40x 1.50x GBX476.40K
2012 5.06% 8.98% 0.42x 1.35x GBX-670.30K
2013 5.51% 9.35% 0.41x 1.42x GBX-651.50K
2014 -154.55% -234.72% 0.36x 1.84x GBX-10.07 Million
2015 -51.73% -37.18% 0.70x 1.98x GBX-2.43 Million
2016 12.26% 11.76% 0.89x 1.17x GBX132.20K
2017 4.56% 7.15% 0.47x 1.35x GBX-745.60K
2018 5.03% 6.61% 0.58x 1.31x GBX-717.30K
2019 -21.48% -24.40% 0.66x 1.34x GBX-3.84 Million
2020 -29.54% -51.76% 0.39x 1.47x GBX-4.38 Million
2021 -4.28% -5.00% 0.58x 1.47x GBX-1.52 Million
2022 2.41% 2.33% 0.73x 1.42x GBX-832.30K
2023 -4.86% -4.24% 0.84x 1.37x GBX-1.56 Million
2024 -22.75% -16.27% 0.98x 1.43x GBX-2.80 Million
2025 -11.71% -7.71% 1.00x 1.52x GBX-1.66 Million

Industry Comparison

This section compares Surgical Innovations Group plc's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $55,786,688
  • Average return on equity (ROE) among peers: -18.43%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Surgical Innovations Group plc (SUN) GBX7.65 Million -18.31% 0.52x $56.75K
AOTI Inc (AOTI) $-5.91 Million 0.00% 0.00x $1.26 Million
Creo Medical Group PLC (CREO) $113.00K 0.00% 0.51x $761.02K
EKF Diagnostics Holdings Plc (EKF) $78.20 Million 14.21% 0.29x $1.35 Million
Inspiration Healthcare Group PLC (IHC) $4.10 Million -31.82% 0.20x $196.37K
NIOX Group PLC (NIOX) $83.80 Million 12.77% 0.09x $3.20 Million
Polarean Imaging Plc (POLX) $8.30 Million -143.22% 0.31x $11.75K
Rua Life Sciences PLC (RUA) $4.11 Million -24.36% 0.32x $181.22K
Smith & Nephew PLC (SN) $273.58 Million 25.01% 1.35x $114.49 Million

About Surgical Innovations Group plc

LSE:SUN UK Medical Devices
Market Cap
$56.75K
GBX466.41 Million GBX
Market Cap Rank
#31477 Global
#1190 in UK
Share Price
GBX0.50
Change (1 day)
+0.00%
52-Week Range
GBX0.45 - GBX0.70
All Time High
GBX4.63
Categories
Companies in UK Medical Devices
About

Surgical Innovations Group plc, together with its subsidiaries, engages in the design, manufacture, and export of medical products for use in laparoscopic and robotic minimally invasive surgery in the United Kingdom, Europe, the Asia Pacific, the United States, and internationally. The company operates through three segments: SI Brand, Original Equipment Manufacturer (OEM), and Distribution. It o… Read more